03.11.2014 Views

hrvatski glasnik intelektualnog vlasništva 05/2005 - Državni zavod ...

hrvatski glasnik intelektualnog vlasništva 05/2005 - Državni zavod ...

hrvatski glasnik intelektualnog vlasništva 05/2005 - Državni zavod ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

1974 HR - Patenti. - Hrvatski <strong>glasnik</strong> <strong>intelektualnog</strong> vlasništva 12, 20<strong>05</strong>, 5, 1897 – 2089<br />

(74) Damir Mijatović, Zagreb, HR<br />

(57) Ovaj izum se odnosi na farmaceutske strukture koje sadrže kao<br />

aktivni princip najmanje jedan spoj formule:<br />

gdje su X, R 1 , R 2 i R 3 kao što su definirani zahtjevom 1 ili njegovu<br />

farmaceutski prihvatljivu sol ili ester, koji se koristi kao inhibitor prolil<br />

oligopeptidaze. Spojevi formule (I) se koriste u liječenju bolesti ili stanja u<br />

kojima su inhibitori prolil oligopeptidaze indicirani kao djelotvorni, na<br />

primjer, u liječenju neurodegenerativnih bolesti kao što su Alzheimerova<br />

bolest ili senilna demencija.<br />

u kojoj R 1 predstavlja radikal -N(R 4 )R 5 , -N(R 4 )-CO-R 5 , -N(R 4 )-SO 2 R 6 ili<br />

jednu od njegovih farmaceutski prihvatljivih soli, nove derivate formule (I),<br />

njihove farmaceutski prihvatljive soli i njihovo pripremanje.<br />

(51) Int.Cl. C 07 D 207/16 7 (10) HR P20<strong>05</strong>02<strong>05</strong> A2<br />

A 61 K 31/40<br />

A 61 P 3/04<br />

A 61 P 3/10<br />

A 61 P 13/08<br />

A 61 P 19/02<br />

A 61 P 19/10<br />

A 61 P 37/00<br />

A 61 P 43/00<br />

(21) P20<strong>05</strong>02<strong>05</strong>A (22) 03. 03.20<strong>05</strong>.<br />

(43) 31. 10.20<strong>05</strong>.<br />

(86) PCT/JP03/010828; 27. 08.2003.<br />

(87) WO04/020407; 11. 03.2004.<br />

(31) 2002-249821 (32) 29. 08.2002. (33) JP<br />

(54) BENZENSULFONATNE SOLI DERIVATA 4-FLUORO-2-<br />

CIJANOPIROLIDINA<br />

BENZENSULFONATE OF 4-FLUORO-2-CYANOPYRROLIDINE<br />

DERIVATIVE<br />

(71) Taisho Pharmaceutical Co., LTD., 24-1, Takata-3-chome, Toshimaku,<br />

Tokyo 170-8633, JP<br />

(72) Hiroshi Fukushima, c/o Taisho Pharmaceutical Co.Ltd., 24-1,<br />

Takata-3-chome, Toshima-ku, Tokyo 170-8633, JP<br />

Akira Hiratete, c/o Taisho Pharmaceutical Co.Ltd., 24-1, Takata 3-<br />

chome, Toshima-ku, Tokyo 170-8633, JP<br />

Masato Takahashi, c/o Taisho Pharmaceutical Co.Ltd., 24-1,<br />

Takata-3-chome, Toshima-ku, Tokyo 170-8633, JP<br />

Kazuya Kameo, c/o Taisho Pharmaceutical Co., Ltd., 24-1, Takata-<br />

3-chome, Toshima-ku, Tokyo 170-8633, JP<br />

(74) Hraste & Partneri odvjetničko društvo, Zagreb, HR<br />

(57) (2S,4S)-2-cijano-4-fluoro-1-[(2-hidroksi-1,1-<br />

dimetil)etilamino]acetilpirolidin benzensulfonat koji pokazuje izvrsnu<br />

aktivnost inhibicije DPPIV i ima svojstva potrebna za lijekove, na primjer,<br />

visoku stabilnost. Ovaj spoj može biti jednostavno dobiven u obliku vrlo<br />

stabilnih kristala koji imaju uniforman oblik i imaju visoku stabilnost<br />

čvrstog stanja.<br />

(51) Int.Cl. C 07 D 207/16 7 (10) HR P20<strong>05</strong>0693 A2<br />

C 07 D 295/18<br />

A 61 K 31/401<br />

A 61 K 31/4025<br />

A 61 K 31/40<br />

(21) P20<strong>05</strong>0693A (22) 02. 08.20<strong>05</strong>.<br />

(43) 31. 10.20<strong>05</strong>.<br />

(86) PCT/FI04/000001; 02. 01.2004.<br />

(87) WO04/060862; 22. 07.2004.<br />

(31) 20030014 (32) 03. 01.2003. (33) FI<br />

(54) SPOJEVI KOJI INHIBIRAJU PROLIL OLIGOPEPTIDAZU<br />

COMPOUNDS HAVING PROLYL OLIGOPEPTIDASE INHIBITORY<br />

ACTIVITY<br />

(71) Orion Corporation, Orionintie 1, 02200 Espoo, FI<br />

(72) Jukka Gynther, Juho Rissasenkatu 17, 7<strong>05</strong>00 Kuopio, FI<br />

Erik Wallén , Vourikatu 4 A 16, 70100 Kuopio, FI<br />

Elina Jarho, Puijonsarventie 29 B 9, 70260 Kuopio, FI<br />

Pekka Männistö, Harmaapaadentie 5 A, 00930 Helsinki, FI<br />

Forsberg Markus, Varsitie 13 C 12, 70150 Kuopio, FI<br />

Antti Poso, Vehnäkuja 3, 76150 Pieksämäki, FI<br />

Johannes Christiaans, Zevenwouden 233, 3524 CR Utrecht, NL<br />

Jarkko Venäläinen, Taivaanpankontie 17 B 15, 70200 Kuopio, FI<br />

Jouko Vepsäläinen, Korpitie 24, 70780 Kuopio, FI<br />

Taija Saarinen, Karistimentie 2 B 32, 00920 Helsinki, FI<br />

Tomi Järvinen, Sompatie 3 I 6, 70200 Kuopio, FI<br />

(74) CPZ - CENTAR ZA PATENTE d.d., ZAGREB, HR<br />

(57) Prikazani izum osigurava spoj formule (I),<br />

(51) Int.Cl. C 07 D 207/325 7 (10) HR P20020643 A2<br />

C 07 D 207/34<br />

A 61 K 31/404<br />

A 61 P 3/00<br />

A 61 P 3/06<br />

(21) P20020643A (22) 30. 07.2002.<br />

(43) 31. 10.20<strong>05</strong>.<br />

(86) PCT/IN01/000<strong>05</strong>; 17. 01.2001.<br />

(87) WO01/53257; 26. 07.2001.<br />

(31) 57/MUM/2000 (32) 19. 01.2000. (33) IN<br />

(54) NOVI SPOJEVI KOJI IMAJU HIPOLIPEDEMIČNE,<br />

HIPOKOLESTEREMIČNE AKTIVNOSTI, POSTUPAK NJIHOVE<br />

PRIPRAVE I FARMACEUTSKI PRIPRAVCI KOJI IH<br />

SADRŽAVAJU<br />

NOVEL COMPOUNDS HAVING HYPOLIPEDEMIC,<br />

HYPOCHOLESTEREMIC ACTIVITIES, PROCESS FOR THEIR<br />

PREPARATION AND PHARMACEUTICAL COMPOSITIONS<br />

CONTAINING THEM<br />

(71) Cadila Healthcare Ltd Zydus Tower, Satellite Cross Roads, RRD<br />

Center, Gandhinagar-Sarkhej Highway, Ahmedabad 380 015<br />

Gujarat, IN<br />

(72) Braj, Bhusham Lohray, Zydus Tower, Satellite Cross Roads,<br />

Gandhinagar-Sarkhej Highway, Ahmedabad 380 015 Gujarat, IN<br />

Vidya, Bhusham Lohray, Cadila Healthcare Ltd., Zydus Tower,<br />

Satellite Cross Roads, Gandhinagar-Sarkhej Highway, Ahmedabad<br />

380 015 Gujarat, IN<br />

Vijay, Kumar, Gajubhai Barot, Cadila Healthcare Ltd., Zydus Tower,<br />

Satellite Cross Roads, Gandhinagar-Sarkhej Highway, Ahmedabad<br />

380 015 Gujarat, IN<br />

(74) Dina Korper Žemva, Zagreb, HR<br />

Zdenko Haramija, Zagreb, HR<br />

(57)<br />

Sadašnji izum se odnosi na nove supstituirane spojeve pirola, njihove<br />

derivate, njihove analoge, njihove tautomerne oblike, njihove<br />

stereoizomere, njihove polimorfe, njihove farmaceutski prihvatljive soli,<br />

njihove farmaceutski prihvatljive solvate i farmaceutski prihvatljive<br />

pripravke koji ih sadržavaju. Ovaj izum se posebno odnosi na nove<br />

supstituirane spojeve pirola općenite formule (I), njihove analoge, njihove<br />

derivate, njihove tautomerne oblike, njihove polimorfe, njihove<br />

farmaceutski prihvatljive soli, njihove farmaceutski prihvatljive solvate i<br />

farmaceutski prihvatljive pripravke koji ih sadržavaju. Ovaj izum se<br />

također odnosi na postupak priprave takvih spojeva, pripravke koji sadrže<br />

takve spojeve i korištenje takvih spojeva i pripravaka u medicini.<br />

(51) Int.Cl. C 07 D 207/34 7 (10) HR P20031039 A2<br />

A 61 K 31/40<br />

(21) P20031039A (22) 16. 12.2003.<br />

(43) 31. 10.20<strong>05</strong>.<br />

(86) PCT/IB02/01796; 21. <strong>05</strong>.2002.<br />

(87) WO03/004470; 16. 01.2003.<br />

(31) 60/302,049 (32) 29. 06.2001. (33) US<br />

(54) KRISTALNI OBLICI KALCIJEVE SOLI [R-(R*,R*)]-2-(4-<br />

FLUORFENIL)-ß, DELTA-DIHIDROKSI-5-(1-METILETIL)-3-FENIL-<br />

4-[(FENILAMINO)KARBONIL]-1H-PIROL-1-HEPTANSKE<br />

KISELINE (2:1) (ATORVASTATINA)<br />

CRYSTALLINE FORMS OF 'R-(R*,R*)!-2-(4-FLUOROPHENYL)-<br />

BETA, DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-<br />

'PHENYLAMINO)CARBONYL!-1H-PYRROLE-1-HEPTANOIC ACID<br />

CALCIUM SALT (2:1) (ATORVASTATIN)<br />

(71) Warner-Lambert Company LLC, 201 Tabor Road, Morris Plains, NJ<br />

07950, US<br />

(72) Stephen Robert Byrn, 824 Barlow Street, West Lafayette, IN 47906,<br />

US<br />

David Andrew Coates, 2435 Neil Armstrong Dr. Apt 24, West<br />

Lafayette, IN 47906, US<br />

Karen Sue Gushurst, 807 Columbia Street, Lafayette, IN 47901, US<br />

Henry Grant Morrison II, 2304 Osage St. Apt. 70, Lafayette, IN<br />

47909, US<br />

Aeri Park, 1717 Soutworth Branch Dr., West Lafayette, IN 47906,<br />

US<br />

ISSN 1331-2030

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!